Skip to main content
Erschienen in: Journal of Cancer Survivorship 4/2022

22.07.2021

Implementing survivorship care planning in two contrasting health systems: lessons learned from a randomized controlled trial

verfasst von: Katherine C. Smith, Sharon White, Jennifer DeSanto, Susan Hannum, Nancy Mayonado, Nita Ahuja, Janice Bowie, David Cowall, Joan Mischtschuk, Kimberly Peairs, Elissa Thorner, Phuoc Tran, Antonio Wolff, Claire Snyder

Erschienen in: Journal of Cancer Survivorship | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

Survivorship care plans (SCPs) are recommended to promote appropriate follow-up care, but implementation has been limited. We conducted a randomized controlled trial comparing three SCP delivery models in two health systems. We utilize mixed methods to compare the feasibility and participants’ perceived value of the three models.

Methods

Patients completing treatment for stage I–III breast, prostate, or colorectal cancer from one urban-academic and one rural community cancer center were randomized to (1) mailed SCP, (2) SCP delivered during an in-person survivorship visit, or (3) SCP delivered during an in-person survivorship visit plus 6-month follow-up. Clinics had flexibility in intervention implementation. Quantitative data summarize intervention fidelity and protocol deviations. Qualitative interview data provide patients’ perspectives on feasibility and intervention value.

Results

Of 475 eligible participants approached, 378 (79%) were randomized. Of 345 SCPs delivered, 265 (76.8%) were by protocol. Protocol deviations were more common at the urban-academic center. In post-study qualitative interviews, participants recalled little about the SCP document or visit(s). SCPs were valued for information and care coordination, although their static nature was limiting, and sometimes SCP information differed from that provided elsewhere. Visits were opportunities for care and reassurance, but time and distance to the clinic were barriers.

Conclusions

SCP provision was challenging. Patients were interested in SCP, but not necessarily additional survivorship visits, particularly at the urban-academic hospital.

Implications for Cancer Survivors

These findings suggest that patients value careful consideration of health care needs during the transition out of treatment; SCP documents are one element of this. For many patients, models without additional visits and dynamic SCPs may be preferred.
Literatur
1.
Zurück zum Zitat Rowland JH, Bellizzi KM. Cancer survivorship issues: life after treatment and implications for an aging population. J Clin Oncol. 2014;32(24):2662 2668.CrossRef Rowland JH, Bellizzi KM. Cancer survivorship issues: life after treatment and implications for an aging population. J Clin Oncol. 2014;32(24):2662 2668.CrossRef
2.
Zurück zum Zitat Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, ... & Rowland JH. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv2015;9(2):239-251. Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, ... & Rowland JH. The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv2015;9(2):239-251.
3.
Zurück zum Zitat Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidem Biomar. 2016;25(7):1029–36.CrossRef Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidem Biomar. 2016;25(7):1029–36.CrossRef
4.
5.
Zurück zum Zitat Keesing S, McNamara B, Rosenwax L. Cancer survivors’ experiences of using survivorship care plans: a systematic review of qualitative studies. J Cancer Surviv. 2015;9(2):260–8.CrossRef Keesing S, McNamara B, Rosenwax L. Cancer survivors’ experiences of using survivorship care plans: a systematic review of qualitative studies. J Cancer Surviv. 2015;9(2):260–8.CrossRef
6.
Zurück zum Zitat Blaes AH, Adamson PC, Foxhall L, Bhatia S. Survivorship care plans and the commission on cancer standards: the increasing need for better strategies to improve the outcome for survivors of cancer. J Oncol Pract. 2020;16(8):447–50.CrossRef Blaes AH, Adamson PC, Foxhall L, Bhatia S. Survivorship care plans and the commission on cancer standards: the increasing need for better strategies to improve the outcome for survivors of cancer. J Oncol Pract. 2020;16(8):447–50.CrossRef
7.
Zurück zum Zitat Kenzik KM, Kvale EA, Rocque GB, Demark-Wahnefried W, Martin MY, Jackson BE, et al. Treatment summaries and follow-up care instructions for cancer survivors: improving survivor self-efficacy and health care utilization. Oncologist. 2016;21(7):817 824.CrossRef Kenzik KM, Kvale EA, Rocque GB, Demark-Wahnefried W, Martin MY, Jackson BE, et al. Treatment summaries and follow-up care instructions for cancer survivors: improving survivor self-efficacy and health care utilization. Oncologist. 2016;21(7):817 824.CrossRef
8.
Zurück zum Zitat Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29(36):4755–62.CrossRef Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29(36):4755–62.CrossRef
9.
Zurück zum Zitat Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ. Survivorship care plans in cancer: a systematic review of care plan outcomes. Brit J Cancer. 2014;111(10):1899–908.CrossRef Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ. Survivorship care plans in cancer: a systematic review of care plan outcomes. Brit J Cancer. 2014;111(10):1899–908.CrossRef
10.
Zurück zum Zitat Birken SA, Raskin S, Zhang Y, Lane G, Zizzi A, Pratt-Chapman M. Survivorship care plan implementation in US cancer programs: a national survey of cancer care providers. J Cancer Educ. 2019;34(3):614–22.CrossRef Birken SA, Raskin S, Zhang Y, Lane G, Zizzi A, Pratt-Chapman M. Survivorship care plan implementation in US cancer programs: a national survey of cancer care providers. J Cancer Educ. 2019;34(3):614–22.CrossRef
11.
Zurück zum Zitat Smith T, Snyder C. Is it time for (Survivorship Care) Plan B? J Clin Oncol. 2011;2(36):4740–1.CrossRef Smith T, Snyder C. Is it time for (Survivorship Care) Plan B? J Clin Oncol. 2011;2(36):4740–1.CrossRef
12.
Zurück zum Zitat Birken SA, Urquhart R, Munoz-Plaza C, Zizzi AR, Haines E, Stover A, ... & Hahn EE. Survivorship care plans: are randomized controlled trials assessing outcomes that are relevant to stakeholders? J Cancer Surviv 2018;12(4): 495-508. Birken SA, Urquhart R, Munoz-Plaza C, Zizzi AR, Haines E, Stover A, ... & Hahn EE. Survivorship care plans: are randomized controlled trials assessing outcomes that are relevant to stakeholders? J Cancer Surviv 2018;12(4): 495-508.
13.
Zurück zum Zitat Choi Y, Smith KC, Shukla A, et al. Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines? Breast Cancer Res Treat. 2020;179:415–24.CrossRef Choi Y, Smith KC, Shukla A, et al. Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines? Breast Cancer Res Treat. 2020;179:415–24.CrossRef
15.
Zurück zum Zitat Birken SA, Clary AS, Bernstein S, Bolton J, Tardif-Douglin M, Mayer DK, ... & Jacobs SR. Strategies for successful survivorship care plan implementation: results from a qualitative study. J Oncol Pract. 2018; 14(8):e462-e483 Birken SA, Clary AS, Bernstein S, Bolton J, Tardif-Douglin M, Mayer DK, ... & Jacobs SR. Strategies for successful survivorship care plan implementation: results from a qualitative study. J Oncol Pract. 2018; 14(8):e462-e483
16.
Zurück zum Zitat Stricker CT, O’Brien M. Implementing the Commission on Cancer’s standards for survivorship care. Clin J Oncol Nurs. 2014;18(Feb2014supplement):15–22.CrossRef Stricker CT, O’Brien M. Implementing the Commission on Cancer’s standards for survivorship care. Clin J Oncol Nurs. 2014;18(Feb2014supplement):15–22.CrossRef
17.
Zurück zum Zitat Isaacson MJ, Hulme PA, Cowan J, Kerkvliet J. Cancer survivorship care plans: processes, effective strategies, and challenges in a Northern Plains rural state. Public Health Nurs. 2018;35(4):91–298.CrossRef Isaacson MJ, Hulme PA, Cowan J, Kerkvliet J. Cancer survivorship care plans: processes, effective strategies, and challenges in a Northern Plains rural state. Public Health Nurs. 2018;35(4):91–298.CrossRef
18.
Zurück zum Zitat Keats MR, Shea K, Parker L, Stewart SA, Flanders A, Bernstein M. After childhood cancer: a qualitative study of family physician, parent/guardian, and survivor information needs and perspectives on long-term follow-up and survivorship care plans. J Cancer Educ. 2019;34(4):638–46.CrossRef Keats MR, Shea K, Parker L, Stewart SA, Flanders A, Bernstein M. After childhood cancer: a qualitative study of family physician, parent/guardian, and survivor information needs and perspectives on long-term follow-up and survivorship care plans. J Cancer Educ. 2019;34(4):638–46.CrossRef
Metadaten
Titel
Implementing survivorship care planning in two contrasting health systems: lessons learned from a randomized controlled trial
verfasst von
Katherine C. Smith
Sharon White
Jennifer DeSanto
Susan Hannum
Nancy Mayonado
Nita Ahuja
Janice Bowie
David Cowall
Joan Mischtschuk
Kimberly Peairs
Elissa Thorner
Phuoc Tran
Antonio Wolff
Claire Snyder
Publikationsdatum
22.07.2021
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 4/2022
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01073-z

Weitere Artikel der Ausgabe 4/2022

Journal of Cancer Survivorship 4/2022 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.